17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
In a decision of interest to private equity investors, the Delaware Court of Chancery (the “Court”...
Read More >
Jobs Report Friday! Here’s what to look for in the numbers – WSJ and Bloomberg and NYTimes The Whi...
Read More >
It is well established that welfare plans are not subject to the vesting requirements of ERISA. Ther...
Read More >
As states and other jurisdictions continue to implement, amend, and clarify their stay-at-home order...
Read More >
There is a lot of confusion about how the California Consumer Privacy Act (CCPA) will impact Califor...
Read More >
Q: When I am hanging out with my HR friends, we frequently discuss employees we wish we’d never hir...
Read More >